echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Prescription drugs available online? Share of medical e-commerce or multiplied

    Prescription drugs available online? Share of medical e-commerce or multiplied

    • Last Update: 2014-05-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: daily economic news 2014-05-29 pharmaceutical e-commerce industry, may usher in another favorable policy promotion On May 28, the State Food and Drug Administration (SFDA) posted the measures for the supervision and administration of Internet food and drug distribution (Draft for comments) (hereinafter referred to as the draft for comments) on its website, and formally solicited the revised comments from the public The reporter of "daily economic news" read the opinion carefully and found that compared with the relevant industrial policies of medical e-commerce in the past, the reform ideas in the opinion broke the two policy barriers that had been adhered to in the past One is that if the requirements are met, regular Internet pharmacies can sell prescription drugs, and the other is that the operation of the third-party transaction and operation platform will be more relaxed "This is a great good I hope the policy can be implemented I support this opinion draft very much, which reflects the industry's aspirations." Shao Qing, vice general manager of Yiling health city and general manager of Yiling pharmaceutical e-commerce business department, may represent the voice of the industry Open online sales of prescription drugs "first" welcome by pharmaceutical e-commerce comments, breaking the taboo of online sales of prescription drugs If this opinion draft can be successfully implemented, "Internet drug dealers shall sell prescription drugs by prescription according to the requirements of drug classification management regulations; the standard, format, validity period, etc of the prescription shall conform to the relevant regulations of prescription management." According to authoritative data, currently there are 129 legal online drug retail enterprises approved by the drug regulatory department, and online drug sales must have the qualification certificate of Internet drug trading service Those who retail drugs to consumers should first be drug retail chain enterprises, and then they should have their own website equipment and management capabilities, in line with the relevant approval regulations Li Guoqing, director of the Department of pharmaceutical and chemical supervision of the State Food and drug administration, told reporters at a meeting that at present, online drug sales businesses of online drug sales enterprises are not profitable, and they need other commodities to make up for it Mainly due to the limitation of prescription source and medical insurance reimbursement, the drugs sold through retail channels only account for 20% of the sales volume of drugs in China According to Li Guoqing, opening up online sales channels does not increase the overall retail volume of drugs Li Guoqing said that as a special commodity, there are special requirements for the storage and transportation of drugs At present, the management level and conditions of ordinary express companies are not up to the requirements for drug distribution, so it is difficult to control the risks of drugs in the process of distribution For the consideration of drug quality assurance, the drug regulatory department is not allowed to entrust social organizations to directly distribute drugs to consumers at present However, with the development of the pharmaceutical e-commerce industry, the regulatory policy of the State Food and drug administration has changed, and for the first time, it shows that the trend of online sale of prescription drugs in Internet pharmacies is about to be relaxed From the perspective of policy orientation, the opinion draft on expanding the share of pharmaceutical e-commerce industry will have a significant positive effect on the pharmaceutical e-commerce industry In Shao Qing's view, for a long time, the domestic pharmaceutical e-commerce industry has been trapped in the policy level tightening, and has not developed on a large scale Data shows that in terms of sales, foreign pharmaceutical e-commerce accounts for about 30% of the total sales, while Chinese pharmaceutical e-commerce accounts for less than 0.1% If the draft can be implemented, the drug price can be effectively reduced, and the monopoly and price raising behavior of relevant large hospitals, pharmaceutical enterprises and local governments in the drug bidding process can be broken "Because the Internet is a completely competitive market, there is no grey rebate and kickback, and there are many business entities, which will naturally generate competition, so as to optimize the market, and can crack down on the behavior of selling fake drugs on the Internet." Shao Qing told reporters that when the online sales of prescription drugs are all normal in the future, it will have a huge impact on the network market of fake drugs, and the market economy will drive these fake drug merchants to be eliminated According to Zhao Zhen, an analyst in Zhuo Chuang's information medicine industry, prescription drugs currently account for 80% of the market share in China, while in the past, pharmaceutical e-commerce only had access to 20% of the market share If the opinion draft is implemented, the market share of the pharmaceutical e-commerce industry will be magnified five times, which is a very big good Zhao Zhen said that he could learn from the experience of developed countries in selling prescription drugs on the Internet for many years "The difficulty of supervision is actually smaller than that of offline drug sales, and the risk is more controllable." Zhao Zhen said that according to the mature monitoring experience in Europe and the United States, in the future, when monitoring, you can backtrack and track the personal information, quantity and time of the seller and the buyer on the network At the time when the network technology and electronic information are mature, it is not difficult to implement the monitoring and control of online drug sales in China In the future, if the regulatory authorities can further liberalize the medical insurance, that is, online drug purchase can be reimbursed through medical insurance, it will "further stimulate the rapid development of this industry" In addition to the sales taboo of prescription drugs, the third-party trading platform is expected to be broken In the opinion draft, policy planning for the third-party trading platform is also made for the first time to further promote the development of the industry It is reported that the third-party trading platform refers to the information network system that provides Web space, virtual business places, trading rules, trade matching, electronic orders and other services for both or more parties to carry out trading activities in the Internet food and drug trading activities It is clear in the opinion draft that the operators of the third-party trading platform shall review the qualifications of the food and drug operators applying for access to the platform, establish registration files and timely verify and update the contents of the operators' open business license, business license or filing information Yang Quanzhu, vice president of China Pharmaceutical Materials Association and chairman of Shanxi Renhe pharmacy chain Co., Ltd., believes that in the field of pharmaceutical circulation, one way worth exploring in the future reform is to promote the establishment of a third-party pharmaceutical logistics platform nationwide as soon as possible In the future, the general trend of the whole industry development is merger and reorganization to improve market concentration The emergence of the third-party logistics trading platform will also be good for the development of the single drugstore, because in the past, according to the existing policies and regulations of the State Food and drug administration, such as the new version of GSP, the single drugstore has put forward relatively strict requirements, the cost of certification is very high, even it is difficult to pass the certification, and the operation in drug distribution is very difficult In Yang Quanzhu's view, if we can join the chain drugstore as soon as possible under the premise of increasingly strict door-to-door delivery requirements in the future, we can complete the distribution by hanging the chain brand, or selling it directly to the chain, or joint venture with the chain, and complete the distribution after integration If the draft is implemented, in the future, "the third-party pharmaceutical logistics platform will play an effective role in the pharmaceutical procurement of upstream supply enterprises and other links of the industrial chain" The most important thing is that it will produce scale effect and highly concentrated market resources, which can reduce drug prices to a certain extent, Yang Quanzhu told reporters  
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.